Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
Pain mechanisms in multiple sclerosis.
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
On the sex ratio of multiple sclerosis.
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Role of microglia in CNS autoimmunity.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
[Progress of demyelinating animal models in the central nervous system].
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
Aggregation of MBP in chronic demyelination.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Pages
« first
‹ previous
…
208
209
210
211
212
213
214
215
216
…
next ›
last »